In non-SCC cancers such as lung adenocarcinoma, several recent reports show that CD109 exhibits a pro-tumorigenic role, even though those reports vary as to the specific intracellular pathways that may mediate the CD109 effects. Here, CD109 is linked to lung adenocarcinoma.